Active surveillance typically involves regular monitoring through PSA tests (for prostate cancer), scheduled MRI scans, biopsies, and physical examinations. The frequency of these tests can vary but usually occurs every three to six months. The goal is to detect any signs of cancer progression early so that curative treatment can be initiated if necessary.
